Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Draegerwerk AG & Co KGaA grew revenues 10.78% from 3.05bn to 3.37bn. In addition the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as a percent of sales). The company reported positive net income, improving from a loss of 64.56m to a profit of 110.43m.
Gross margin43.51%
Net profit margin3.41%
Operating margin5.30%
Return on assets3.80%
Return on equity8.06%
Return on investment5.61%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Draegerwerk AG & Co KGaA fell by 39.60m. However, the company earned 189.68m from its operations for a Cash Flow Margin of 5.62%. In addition the company used 67.34m on investing activities and also paid 154.56m in financing cash flows.
Cash flow per share13.75
Price/Cash flow per share3.06
Book value per share76.45
Tangible book value per share58.20
More ▼

Balance sheet in EURView more

Draegerwerk AG & Co KGaA has a Debt to Total Capital ratio of 17.04%, a lower figure than the previous year's 18.71%.
Current ratio1.89
Quick ratio1.10
Total debt/total equity0.2057
Total debt/total capital0.1704
More ▼

Growth rates in EUR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 1,238.46% and 271.05%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
Div yield(5 year avg)0.99%
Div growth rate (5 year)55.73%
Payout ratio (TTM)29.23%
EPS growth(5 years)32.41
EPS (TTM) vs
TTM 1 year ago
21.04
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.